Succinate is widely accepted as an inflammatory signal and induces interleukin-1β (IL-1β) through HIF-1α [89] while IL-1β has been demonstrated to be elevated in colorectal cancer [90], oral cancer [91] and colon cancer [92]. The gene discussed is IL1B; the disease is colorectal cancer.